Malignant effusions contain lysophosphatidic acid (LPA)-like activity

Area of Science:

• Biochemistry
• Oncology
• Cell Biology

Background:

• Bioactive phospholipids like lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) exhibit growth factor-like activities via cell-surface receptors.
• LPA is implicated as a growth factor in ovarian cancer ascites.
• This study investigated LPA-like activity in patient effusions, hypothesizing higher levels in ovarian cancer.

Purpose of the Study:

• To quantify LPA-like bioactivity in effusions from cancer patients.
• To compare LPA-equivalent levels between ovarian cancer patients and those with other malignancies.
• To explore correlations between LPA-equivalent levels and clinical/biochemical parameters.

Main Methods:

• A neurite retraction bioassay using a neuroblastoma cell line was employed to detect LPA activity.
• Bioactivity was quantified as virtual LPA-equivalent levels.
• Effusions from 62 patients, including 13 with ovarian cancer, were analyzed.

Main Results:

• Average LPA-equivalent levels were significantly higher in ovarian cancer patients (94.5 microns) compared to the overall patient group (50.2 microns) (P = 0.004).
• Ovarian cancer patient effusion levels ranged from 15-200 microns, while the overall group ranged from 5.4-200 microns.
• No significant independent correlations were found between LPA-equivalent levels and other clinical or biochemical characteristics.

Conclusions:

• Elevated LPA-like lipid levels in ovarian cancer effusions suggest a potential role in disease progression.
• These findings may also apply to other intraperitoneal malignancies.
• Further research into LPA's role in peritoneal cancer spread is warranted.